To review the available data on non-surgical management for neurogenic lower urinary tract
dysfunction (NLUTD) in patients with chronic spinal cord injury (SCI) and provide the most …

Botulinum toxin A (Botox) had been considered a promising drug that has an effect on
functional disorders of the lower urinary tract. Because Botox exhibits anti-inflammatory and …

Background Idiopathic functional urinary outflow tract obstruction (iFUOTO) is an uncommon
but life‐limiting disease whose etiology and clinical course of disease remain poorly …

Increasing of treatment efficiency in patients with neurogenic detrusor overactivity is an
important medical and social problem. Its significance is determined not only by the high …

Bladder Sphincter Dyssynergia - Abstract - Europe PMC Sign in | Create an account https://orcid.org
Europe PMC Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter Blog …

Introduction: Botulinum toxin A (BoNT-A) injections in the prostate gland have been used as
a minimally invasive option for treating bladder outlet obstruction (BOO). However, the …

2017; 31: 780–785. 3. Haddad M, Emiliani E, Rouchausse Y, et al. Impact of laser fiber tip
cleavage on power output for ureteroscopy and stone treatment. World J Urol. 2017; 35 …

Introduction: To compare the efficacy of paraurethral BoNT-A injection and a combination of
muscle relaxant and alpha-blocker medication in patients with supra-sacral spinal cord …

This chapter aims to work through the current understanding of types of non-neurogenic
voiding dysfunction (VD) in women, recommended investigation, assessment and …

Botulinum toxin A (BoNT-A) is used sparingly in detrusor external sphincter dyssynergia
(DESD) and that was the primary reason we conducted this systematic review. DESD is a …